Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511254-51-00

Acronym

EyeD-010-003

Enrollment

Registered

2024-05-10

Start date

2023-02-09

Completion date

2025-06-26

Last updated

2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026